These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27279275)

  • 1. Ag85A/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice.
    Liang Y; Bai X; Zhang J; Song J; Yang Y; Yu Q; Li N; Wu X
    Mol Med Rep; 2016 Aug; 14(2):1146-52. PubMed ID: 27279275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.
    Liang Y; Wu X; Zhang J; Xiao L; Yang Y; Bai X; Yu Q; Li Z; Bi L; Li N; Wu X
    FEMS Immunol Med Microbiol; 2012 Dec; 66(3):419-26. PubMed ID: 23163873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy.
    Li Z; Song D; Zhang H; He W; Fan X; Zhang Y; Huang J; Wang X; Liu Q; Xiong S
    DNA Cell Biol; 2006 Jan; 25(1):25-30. PubMed ID: 16405398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
    Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
    Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
    Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
    Deng YH; He HY; Zhang BS
    J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.
    Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z
    Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
    Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
    J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
    Fan X; Gao Q; Fu R
    Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.
    Lu J; Wang C; Zhou Z; Zhang Y; Cao T; Shi C; Chen Z; Chen L; Cai C; Fan X
    Clin Dev Immunol; 2011; 2011():617892. PubMed ID: 21461375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.
    Olsen AW; Williams A; Okkels LM; Hatch G; Andersen P
    Infect Immun; 2004 Oct; 72(10):6148-50. PubMed ID: 15385521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.
    Parlane NA; Wedlock DN; Buddle BM; Rehm BH
    Appl Environ Microbiol; 2009 Dec; 75(24):7739-44. PubMed ID: 19837843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.
    Parlane NA; Grage K; Mifune J; Basaraba RJ; Wedlock DN; Rehm BH; Buddle BM
    Clin Vaccine Immunol; 2012 Jan; 19(1):37-44. PubMed ID: 22072720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.
    Romano M; Roupie V; Wang XM; Denis O; Jurion F; Adnet PY; Laali R; Huygen K
    Immunology; 2006 Jul; 118(3):321-32. PubMed ID: 16827893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
    Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice.
    Sun L; Yuan Q; Xu T; Yao L; Feng J; Ma J; Wang L; Lv C; Wang D
    Biotechnol Lett; 2017 Aug; 39(8):1159-1166. PubMed ID: 28470626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
    Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
    Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.